Skip to content

Effectiveness of Ayurvedic Formulation for COVID 19

Clinical evaluation of YASH-T decoction in the management of mild to moderate COVID-19 cases: Open label controlled trial

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/026978
Enrollment
100
Registered
2020-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Ayurvedic PolyHerbal Formulation: Polyherbal formulation will be given as the decocotion to the intervention group two times a day for 4 weeks in the intervention group Other group will

Sponsors

Nepal Health Research COuncil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 to 70 years COVID-19 patients confirmed by RT-PCR testing within 4 days Symptomatic COVID-19 patients with Mild to Moderate Confirmed cases of COVID-19 in hospital with asymptomatic cases Participation of the subject is voluntary

Exclusion criteria

Exclusion criteria: Children below 18 years Immunocompromised patients (HIV, Cancer, etc.) Co-morbid patients of HTN, COPD, Diabetes, Malignant tumour Pregnant women Severe or immediately life-threatening COVID-19 case Surgery undergone within past 6 months Patients of moderate to severe liver disease Patients of chronic kidney disease Drug Sensitivity

Design outcomes

Primary

MeasureTime frame
Duration of the positive to Negative Conversion of SARS-COV2Timepoint: 4 weeks

Secondary

MeasureTime frame
Changes in the hematological parameters Changes in the immunological parameters Complications due to COVID 19Timepoint: one week, two weeks, three weeks and 4 weeks

Countries

Nepal

Contacts

Public ContactShristi Karki

Nepal Health Research Council

shristi.karki1@gmail.com9808426339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026